Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: USPTO action...'148 Non final action mailed today in Transaction History eom

Based on the letter written by the examiner, after the last non-final action was discussed in person with Moore and the lawyers...the examiners stance is that claims 4 and 8 are deemed "anticipated" by Kajigaya and are unpatentable based on Bugula and Hashimoto.

Our stance is thst we differ from the "instant invention" in that "Kajigaya reference does not use a ring oscillator to provide a system clock to the microprocessor and a microprocessor that operates based on program instructions" and..."the secondary reference to Hashimoto was argued as not driving a microprocessor."

Interestingly, his last statement says "the examiner would reconsider the rejections based on written arguments" by the patent holder...maybe our followup letter wasn't as convincing as we would have hoped.

Share
New Message
Please login to post a reply